Posts Tagged: Affordable Drugs VI v. Celgene Corporation


Do Recent Decisions Signal a Change in Patent Owner’s Rights to Defend and Amend Claims in Post-Grant Proceedings?

Ever since the introduction of AIA post-grant proceedings, many have questioned whether the procedural deck is stacked against patent owners.  Limits on making claim amendments, having to …
By David Thibodeau
6 months ago 7

Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close